Pharmaceutical Compositions
OwnerYong Cui, Maura Murphy +4inventors
InventorsYong Cui, Maura Murphy, Kirk Dinehart, Patricia Hurter, Patrick R. Connelly, Riccardo N. Panicucci
Life of this patent
Estimating the term…
Abstract
Forms and formulations of VX-950 and uses thereof.
Claims79
(canceled)
(canceled)
A spray-dried dispersion comprising VX-950, HPMCAS and about 1% wt/wt sodium lauiyl sulfate.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A pharmaceutical composition comprising a mixture of:
- VX-950, wherein said VX-950 comprises about 30-75% wt/wt of the pharmaceutical composition,
- HPMCAS, wherein
- said HPMCAS comprises about 30-75% wt/wt of the pharmaceutical composition, and
- sodium lauryl sulfate, wherein said sodium lauryl sulfate comprises about 0.5-2% wt/wt of the pharmaceutical composition,
- wherein the mixtures is combined with acetone and methylene chloride and spray-dried to form a solid.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.